Functional effects of β1-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without b-blocker administration

Clinical Research in Cardiology

Volumn 100, Issue 2, 2011, Pages 129-137

  Kindermann, Michael ^a   Seeland, Ute ^a   Ruhnke, Patrick ^a   Böhm, Michael ^a   Maack, Christoph ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Adrenoceptor; Hemodynami; Polymorphisms

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; DOBUTAMINE; METOPROLOL SUCCINATE;

ADULT; ARTICLE; BODY SURFACE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE FREQUENCY; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; DOBUTAMINE; DRUG COMBINATIONS; EXERCISE TEST; HEART VENTRICLES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-1; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 79954420268     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0221-z     Document Type: Article

References (34)

1. Brodde OE, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51(4):651-690
2. Kirstein SL, Insel PA (2004) Autonomic nervous system pharmacogenomics: A progress report. Pharmacol Rev 56(1):31-52 (Pubitemid 38314579)
3. Leineweber K, Büscher R, Bruck H, Brodde OE (2004) Betaadrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 369(1):1-22
4. Maqbool A, Hall AS, Ball SG, Balmforth AJ (1999) Common polymorphisms of beta1-adrenoceptor: Identification and rapid screening assay. Lancet 353(9156):897 (Pubitemid 29126881)
5. Joseph SS, Lynham JA, Grace AA, Colledge WH, Kaumann AJ (2004) Markedly reduced effects of (-)-isoprenaline but not of (-)-cgp12177 and unchanged affinity of beta-blockers at gly389- beta1-adrenoceptors compared to arg389-beta1-adrenoceptors. Br J Pharmacol 142(1):51-56 (Pubitemid 38698193)
6. Mason DA, Moore JD, Green SA, Liggett SB (1999) A gainof- function polymorphism in a g-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274(18): 12670-12674
7. Molenaar P, Rabnott G, Yang I, Fong KM, Savarimuthu SM, Li L, West MJ, Russell FD (2002) Conservation of the cardiostimulant effects of (-)-norepinephrine across ser49gly and gly389arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 40(7):1275-1282
8. Sandilands AJ, O'Shaughnessy KM, Brown MJ (2003) Greater inotropic and cyclic amp responses evoked by noradrenaline through arg389 beta 1-adrenoceptors versus gly389 beta 1- adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138(2):386-392 (Pubitemid 36188600)
9. Büscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S, Hoyer PF, Michel MC, Insel PA, Brodde OE (2001) In vivo studies do not support a major functional role for the gly389arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 11(3):199-205 (Pubitemid 32319869)
10. Leineweber K, Bruck H, Temme T, Heusch G, Philipp T, Brodde OE (2006) The arg389gly beta1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine. Pharmacogenet Genomics 16(1):9-13 (Pubitemid 41803872)
11. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA, Prasad HC, Byrne DW, Nair UB, Wood AJ, Stein CM (2003) A common beta1-adrenergic receptor polymorphism (arg389gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 73(4):366-371 (Pubitemid 36403596)
12. Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, Stein CM (2001) Arg389gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11(3):191-197 (Pubitemid 32319868)
13. Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde OE (2005) The arg389gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol 46(11):2111-2115 (Pubitemid 41713600)
14. La Rosee K, Huntgeburth M, Rosenkranz S, Bohm M, Schnabel P (2004) The arg389gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 14(11):711-716 (Pubitemid 39552785)
15. Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, Zhou HH (2003) Gly389arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 74(4):372-379 (Pubitemid 37222858)
16. Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB (2003) Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9(10):1300-1305 (Pubitemid 37279854)
17. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ (2000) The gain-of-function g389r variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to betablockade in hypertensive subjects. Clin Sci (Lond) 99(3):233-238
18. Brodde OE, Bruck H, Leineweber K (2006) Cardiac adrenoceptors: Physiological and pathophysiological relevance. J Pharmacol Sci 100(5):323-337 (Pubitemid 44609527)
19. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y (2002) The myocardium-protective gly-49 variant of the beta 1- adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277(34): 30429-30435 (Pubitemid 34970733)
20. Rathz DA, Brown KM, Kramer LA, Liggett SB (2002) Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39(2):155-160 (Pubitemid 34093534)
21. McLennan FM, Haites NE, Mackenzie JD, Daniel MK, Rawles JM (1986) Reproducibility of linear cardiac output measurement by Doppler ultrasound alone. Br Heart J 55(1):25-31 (Pubitemid 16131404)
22. Kindermann M, Maack C, Schaller S, Finkler N, Schmidt KI, Laer S, Wuttke H, Schafers HJ, Bohm M (2004) Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. Circulation 109(25): 3182-3190
23. Grossman W, Jones D, McLaurin LP (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56(1):56-64
24. Reichek N, Wilson J, St John Sutton M, Plappert TA, Goldberg S, Hirshfeld JW (1982) Noninvasive determination of left ventricular end-systolic stress: Validation of the method and initial application. Circulation 65(1):99-108 (Pubitemid 12250896)
25. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57(6):450-458 (Pubitemid 16119719)
26. Aquilante CL, Yarandi HN, Cavallari LH, Andrisin TE, Terra SG, Lewis JF, Hamilton KK, Johnson JA (2008) Beta-adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography. Pharmacogenomics J 8(6):408-415
27. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L, Groop L (2001) Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 104(2):187-190 (Pubitemid 32655836)
28. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL, Wallace MR, Lewis JF, McNamara DM, Picoult- Newberg L, Pepine CJ, Johnson JA (2001) Effects of beta1- adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 88(9):1034-1037 (Pubitemid 33042620)
29. Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, Hartiala J, Scheinin M (2003) Effects of common polymorphisms in the alpha1a-, alpha2b-, beta1- and beta2- adrenoreceptors on haemodynamic responses to adrenaline. Clin Sci (Lond) 104(5):509-520 (Pubitemid 36628147)
30. Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hill JA, Aranda JM, Yarandi HN, Johnson JA (2005) Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. Pharmacogenet Genomics 15(4):227-234 (Pubitemid 40569894)
31. Ruffolo RR Jr (1987) The pharmacology of dobutamine. Am J Med Sci 294(4):244-248
32. Von Scheidt W, Böhm M, Stablein A, Autenrieth G, Erdmann E (1992) Antiadrenergic effect of m-cholinoceptor stimulation on human ventricular contractility in vivo. Am J Physiol 263(6 Pt 2):H1927-H1931 (Pubitemid 23030750)
33. Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P (2007) Arg389glybeta1- adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. Pharmacogenet Genomics 17(11):941-949 (Pubitemid 350293794)
34. Karlsson J, Lind L, Hallberg P, Michaelsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Melhus H (2004) Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol 27(6):347-350 (Pubitemid 38703089)